Departments of *Pathology and Laboratory Medicine, Rhode Island Hospital †Pathology and Laboratory Medicine, Women and Infants Hospital of Rhode Island ‡Pathology and Laboratory Medicine §Pathology and Laboratory Medicine, The Miriam Hospital, Alpert Medical School of Brown University, Providence, RI.
Am J Surg Pathol. 2017 Mar;41(3):382-388. doi: 10.1097/PAS.0000000000000809.
Routine histopathologic examination of hemorrhoidectomy specimens is controversial having been described as not useful and expensive with few of these common cases demonstrating incidental lesions. However, unexpected premalignant and malignant lesions have been detected on excised hemorrhoids. The high-risk human papillomavirus (HR-HPV) types associated with these incidentally identified high-grade lesions are presently unknown. We aimed to identify cases of incidental high-grade anal intraepithelial neoplasia (HG-AIN) and anal squamous cell carcinoma incidentally discovered on hemorrhoidectomy specimens, genotype HR-HPVs from these lesions, and assess p53 and p16 expression by immunohistochemistry to identify risk factors for their development. With institutional approval, cases with associated demographics from 1995 to 2015 were reviewed to identify and confirm incidental HG-AIN or squamous cell carcinoma in hemorrhoidectomy specimens. Genotyping for HR-HPV types and immunohistochemical staining for p53 and p16 was performed. Statistical analysis comparing HPV genotypes, p53 and p16 staining, and potential risk factors by the Fisher exact test was performed. In the largest series of incidental high-grade lesions on hemorrhoidectomy, HPV 16 was the most common HR-HPV detected though multiple-type infections were common including some HPV 16/18-negative cases. By genotyping, HPV 39 was significantly associated with IV-drug abuse history (P=0.0015) and HIV-positive status (P=0.037), whereas HPV 58 detection correlated with chemotherapy-induced immunosuppression (P=0.029). There was frequent overlap between p53 staining and HPV positivity, particularly when HPV 31 was detected. We also identified several mimickers of HG-AIN that may present diagnostic challenges in these specimens. Our data support continued routine examination of hemorrhoidectomy specimens and suggest that adjunctive studies such as immunohistochemistry for challenging cases may be useful.
常规的痔切除术标本组织病理学检查存在争议,有人认为其没有用处且费用昂贵,因为这些常见病例中很少有偶然发现的病变。然而,在切除的痔中已经发现了意外的癌前和恶性病变。目前尚不清楚与这些偶然发现的高级别病变相关的高危型人乳头瘤病毒(HR-HPV)类型。我们的目的是确定在痔切除术标本中偶然发现的高级别肛门上皮内瘤变(HG-AIN)和肛门鳞状细胞癌的病例,从这些病变中检测 HR-HPV 基因型,并通过免疫组织化学评估 p53 和 p16 的表达,以确定其发展的危险因素。在获得机构批准的情况下,回顾了 1995 年至 2015 年的相关病例,以确定和确认痔切除术标本中偶然发现的 HG-AIN 或鳞状细胞癌。进行 HR-HPV 类型的基因分型和 p53 和 p16 的免疫组织化学染色。通过 Fisher 确切检验比较 HPV 基因型、p53 和 p16 染色以及潜在的危险因素进行统计学分析。在痔切除术标本中偶然发现的高级别病变的最大系列中,HPV 16 是最常见的 HR-HPV,但多种类型的感染很常见,包括一些 HPV 16/18 阴性病例。通过基因分型,HPV 39 与 IV 药物滥用史(P=0.0015)和 HIV 阳性状态(P=0.037)显著相关,而 HPV 58 的检测与化疗引起的免疫抑制相关(P=0.029)。p53 染色与 HPV 阳性之间经常重叠,特别是当检测到 HPV 31 时。我们还确定了一些可能在这些标本中存在诊断挑战的 HG-AIN 的模拟物。我们的数据支持继续对痔切除术标本进行常规检查,并表明对于具有挑战性的病例,辅助研究(如免疫组织化学)可能是有用的。